| Company Name: |
Biolab Reagents |
| Tel: |
027-65279366 18108604356 |
| Email: |
products@biolabreagent.com |
|
| | Cirevetmab Basic information |
| Product Name: | Cirevetmab | | Synonyms: | Cirevetmab;Research Grade Cirevetmab (DQB91601);Research Grade Cirevetmab | | CAS: | 2473240-98-9 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Cirevetmab Structure]() |
| | Cirevetmab Chemical Properties |
| | Cirevetmab Usage And Synthesis |
| Uses | Cirevetmab (ZTS-00521426) is an immunoglobulin G2-kappa, Canis lupus familiaris TGFB1 caninized monoclonal antibody. Cirevetmab is an immunomodulator[1]. | | References | [1] International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 35, No. 4, 2021. |
| | Cirevetmab Preparation Products And Raw materials |
|